Average Co-Inventor Count = 3.49
ph-index = 36
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. G.d. Searle & Company (52 from 1,323 patents)
2. Deciphera Pharmaceuticals, LLC (44 from 82 patents)
3. Warner-lambert Company (20 from 2,536 patents)
4. Pharmacia Corporation (6 from 200 patents)
5. Eli Lilly and Company (2 from 4,419 patents)
6. Millennium Pharmaceuticals Limited (1 from 847 patents)
7. Deciphera Pharmaceuticals, Lls (1 from 1 patent)
124 patents:
1. 12377097 - Aminopyrimidine amide autophagy inhibitors and methods of use thereof
2. 12319655 - RAF kinase inhibitors and methods of use thereof
3. 12285430 - Methods of treating disorders using CSF1R inhibitors
4. 12102620 - Combination therapy for the treatment of mastocytosis
5. 12071432 - Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
6. 11986463 - Combination therapy for the treatment of gastrointestinal stromal tumor
7. 11912668 - GCN2 and perk kinase inhibitors and methods of use thereof
8. 11801238 - Anti-viral activity of VPS34 inhibitors
9. 11679110 - Methods of treating disorders using CSF1R inhibitors
10. 11590134 - Aminopyrimidine amide autophagy inhibitors and methods of use thereof
11. 11530206 - Phenylaminopyrimidine amide autophagy inhibitors and methods of use thereof
12. 11518758 - Heteroarylaminopyrimidine amide autophagy inhibitors and methods of use thereof
13. RE48731 - Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
14. 11103507 - Methods of treating disorders using CSF1R inhibitors
15. 9457019 - Methods for inhibiting tie-2 kinase useful in the treatment of cancer